cgp 12177 has been researched along with mirabegron in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maruyama, T; Matsui, T; Miyata, K; Nagase, I; Sasamata, M; Sato, S; Takasu, T; Uchida, H; Ukai, M; Yamaguchi, O | 1 |
Alewijnse, AE; Michel, MC; Vrydag, W | 1 |
2 other study(ies) available for cgp 12177 and mirabegron
Article | Year |
---|---|
Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Animals; Carbachol; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Humans; Isoproterenol; Muscle Contraction; Propanolamines; Thiazoles; Urinary Bladder | 2007 |
Do gene polymorphisms alone or in combination affect the function of human beta3-adrenoceptors?
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Binding, Competitive; Biphenyl Compounds; Cell Line; Cyclic AMP; Humans; Isoproterenol; Mutagenesis, Site-Directed; Norepinephrine; Phenethylamines; Polymorphism, Single Nucleotide; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta-3; Thiazoles; Transfection | 2009 |